Record 031 · Therapeutics · 2021
50%21.31.X
Immorta Bio
Immorta Bio
“Personalized regenerative immunotherapies against aging and cancer.”
Immorta Bio works on patient-derived regenerative and immune approaches. Small, ambitious, filed as a therapeutics line not a clinic.
Therapeutics at the immune-aging seam.
Pre-seed & seed. Filed from the Top Tier Impact landscape.
- Personalized immune
- Aging + oncology
Immune, then regenerate.